Volume 11 • Issue 6 • June 2017
ISSN 1814 3601
Figure 1. Distribution of confirmed measles cases with rash onset 1–31 May 2017, WHO Western Pacific Region
Legend: No confirmed case With confirmed case No case based data Dots are placed at random within the corresponding district, and might not reflect the exact location of the case
DISCLAIMER: The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO Regional Office for the Western Pacific 2009. All rights reserved *Map of Australia is from the Australian Bureau of Statistics
Source: Measles and rubella monthly country reports to the Western Pacific Regional Office by 20 June 2017
Table 1. Confirmed measles cases by month of rash onset, June 2016–May 2017, WHO Western Pacific Region Country/area Australia Brunei Darussalam Cambodia China China, Hong Kong SAR China, Macao SAR Japan Lao People's Democratic Republic Malaysia Mongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam Pacific island countries and areas Western Pacific Region "-" No data
2016 Jun 4 0 4 2619 2 0 3 0 113 79 29 0 3 0 6 3 1 2866 Jul 6 0 5 1695 0 0 5 0 70 22 5 0 3 0 3 6 0 1820 Aug 1 1 11 866 0 0 76 0 104 4 3 0 4 1 8 3 0 1082 Sep 7 0 1 350 1 0 43 0 88 2 1 0 6 8 7 1 0 515 Oct 7 0 9 208 0 0 10 0 78 2 1 0 8 4 11 2 0 340 Nov 6 0 12 222 0 0 2 0 60 2 0 0 4 0 24 0 0 332 Dec 16 0 10 531 3 0 5 8 67 4 0 0 3 0 16 0 0 663 Jan 9 0 4 306 1 0 15 3 74 2 6 0 4 1 9 1 0 435 Feb 7 0 5 437 1 0 26 0 53 1 2 0 2 0 10 0 0 544
2017 Mar 25 0 0 651 0 0 67 0 117 4 2 0 5 2 9 0 0 882 Apr 7 0 0 830 0 0 36 0 126 2 0 0 2 0 5 3 0 1011 May 4 0 0 809 0 0 3 0 86 0 4 0 0 1 4 1 1 913
Source: Case based and aggregate data reports to the Western Pacific Regional Office by 20 June 2017
Figure 2. Confirmed and compatible measles cases by month of rash onset, WHO Western Pacific Region, 2012–2017 as of 20 June 2017 25 000
20 000
Number of measles cases
15 000
10 000
5 000
0 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May 2012 2013 2014 2015 2016 2017
China
Philippines
Viet Nam
Malaysia
Papua New Guinea
Mongolia
Others
Source: Measles and rubella monthly country reports to WHO by 20 June 2017 Includes laboratory confirmed, epi-linked and clinically confirmed cases for 2012
Table 2. Status of measles verification, WHO Western Pacific Region 2016 Country/area Year No. of cases Australia Brunei Darussalam Cambodia China China, Hong Kong SAR China, Macao SAR Japan Lao People's Democratic Republic Malaysia Mongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam Pacific island countries and areas Total 2014 2015 2015 2016 2014 2015 2014 99 1 56 23 960 9 0 152 8 1 577 3 587 104 0 74 18 140 36 6 29 827 Imported 31 1 0 0 1 27 0 5 0 0 1 9 16 0 0 91 Source of infection Importrelated 18 0 0 0 0 97 0 0 2 392 0 0 9 90 0 0 2 606 Unknown / not reported 50 0 56 23 960 8 28 8 69 0 104 53 0 34 36 6 24 412 % of c ases w ith
2017 No. of confirmed cases 52 0 9 3 033 3 0 158 3 456 9 14 0 19 4 37 5 1 3 803 No measles cases ≥80% 60–79% <60% Imported 23 0 0 2 28 0 2 0 0 0 3 8 0 0 66 Source of infection Importrelated 5 0 0 0 118 0 0 0 0 0 0 15 0 0 138 Unknown / not reported 24 9 3 033 1 12 3 192 9 14 12 1 14 5 1 3 330 % of c ases w ith know n
verified confirmed
Endemic sourc e of infec tion
know n
Endemic sourc e of infec tion
0 0 0 0 0 0 0 1 503 1 195 0 20 0 0 0 0 2 718
49.5% 100.0% 0.0% 0.0% 11.1% 81.6% 0.0% 95.6% 100.0% 0.0% 28.4% 100.0% 75.7% 0.0% 0.0% 18.2% Blue Green Yellow Red
0 0 0 0 0 0 262 0 0 7 0 0 0 0 269
53.8% 0.0% 0.0% 66.7% 92.4% 0.0% 57.9% 0.0% 0.0% 36.8% 75.0% 62.2% 0.0% 0.0% 12.4%
Source: Measles and rubella monthly country reports to WHO by 20 June 2017
2
Table 3. Measles case classification and incidence by country and area, WHO Western Pacific Region, 2013 —2017 as of 20 June 2017 2013 Total Country/area confirmed and compatible1 Australia Brunei Darussalam Cambodia China China, Hong Kong SAR China, Macao SAR Japan Lao People's Democratic Republic Malaysia Mongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam Pacific island countries and areas4 Western Pacific Region 1 2 3 4
2014 Measles Total confirmed and compatible1 340 0 0 52 485 50 1 454 70 222 0 274 2 589 54 669 442 171 16 741 278 128 786 Measles incidence per 1 million pop. 14.5 0.0 0.0 38.5 6.8 1.7 3.6 10.7 7.3 0.0 60.2 345.9 548.0 9.0 32.0 182.8 85.0 70.1 Total
2015 Measles incidence per 1 million pop. 3.3 9.0 0.0 30.7 2.4 0.0 0.3 8.0 43.9 7136.8 2.9 6.9 19.7 0.1 8.9 9.4 6.1 36.2 Total
2016 Measles incidence per 1 million pop. 4.1 2.3 3.5 18.0 1.2 0.0 1.2 1.2 51.6 9583.7 22.8 0.0 6.3 0.4 27.6 3.9 1.8 30.5 Green Yellow Red
2017 Confirmed and compatible measles cases Population (in millions) 2
Rash onset of Deaths due to last confirmed measles case 26-May-17 7-Aug-16 26-Feb-17 31-May-17 29-Apr-17 3-Jun-14 12-May-17 10-Jan-17 26-May-17 5-May-17 25-May-17 21-Sep-15 9-May-17 19-Mar-17 12-May-17 12-May-17 1-May-17
incidence per 1 million pop. 6.6 0.0 0.0 20.5 5.2 5.2 1.6 10.5 6.1 0.0 2.9 1.0 59.1 2.2 12.5 13.6 0.0 19.5
confirmed and compatible1 74 4 0 42 864 18 0 35 56 1 318 20 374 13 53 2 003 7 45 884 20 67 768
confirmed and compatible1 99 1 56 24 839 9 0 157 8 1 587 28 813 104 0 641 18 157 368 6 56 863
Suspected measles cases 3
Pending classification
Discarded cases 3
Compatible cases
Lab
Epi-linked
Total confirmed and 52 0 9 3 815 3 0 160 3 508 9 14 0 269 4 45 103 1 4 995
Annualized measles
incidence per measles 5.1 0.0 1.3 6.6 1.0 0.0 3.0 1.0 39.1 7.1 7.3 0.0 6.2 0.2 18.7 2.6 0.7 6.4 0 0 0 3 0 0 0 0 0 0 0 0 0 0 0 0 0 3
compatible 1 million pop. 24.6 0.4 16.1 1388.2 7.4 0.6 126.0 7.0 31.2 3.1 4.6 7.9 103.8 50.7 5.8 95.4 3.3 1876.2 NA 0 0 6 763 0 0 4 68 348 0 10 0 125 0 0 33 3 1 360 0 1 313 10 012 7 6 236 174 2 418 96 0 5 886 100 41 319 32 14 646 0 0 0 782 0 0 2 0 52 0 0 0 250 0 8 98 0 1 192 49 0 9 3 014 3 0 154 2 455 9 11 0 19 4 37 5 1 3 772 3 0 0 19 0 0 4 1 1 0 3 0 0 0 0 0 0 31
154 0 0 27825 38 3 207 68 182 0 13 7 5798 107 66 1232 0 35 700
1 328 14 590 10 6 400 245 3 274 105 24 5 1 280 104 86 455 36 20 949
Includes compatible, laboratory confirmed and epi-linked confirmed cases United Nations, Department of Economic and Social Affairs, Population Division World Population Prospects. Australia reports confirmed cases only. Classification is provisional based on laboratory data only.
<1 confirmed measles case / 1 000 000 population 1–9.9 confirmed measles case / 1 000 000 population >= 10 confirmed cases / 1 000 000 population
3
Table 4. Measles surveillance performance indicators by country and area, WHO Western Pacific Region, 2016 —2017 as of 20 June 2017 2016 Discarded non-measles Second level units with ≥ 2 discarded cases per 100 000 pop [annualized]1 Suspected cases with adequate investigation Suspected cases with adequate specimens for laboratory confirmation 2
2017 Annualized discarded non-measles rate per 100 000 pop Second level units with ≥ 2 discarded cases per 100 000 pop [annualized]1 Suspected cases with adequate investigation Suspected cases with adequate specimens for laboratory confirmation 2
Country/area
rate per 100 000 pop
≥2
≥ 80% Insufficient data Not applicable
≥ 80% Insufficient data
≥ 80% Insufficient data
≥2 Insufficient data
≥ 80% Insufficient data Not applicable
≥ 80% Insufficient data
≥ 80% Insufficient data
Australia 3 Brunei Darussalam Cambodia China China, Hong Kong SAR China, Macao SAR Japan Lao People's Democratic Republic Malaysia Mongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam Pacific island countries and areas Western Pacific Region 1
Insufficient data
2.8 4.2 3.2 2.5 2.0 0.7 7.3 16.1 46.4 1.1 0.6 1.5 0.6 4
100.0% 88.3% 97.1% 97.9% 100.0% Insufficient data
100.0% 99.0% 87.9% 99.5% 100.0% Insufficient data
0.0 4.7 1.7 0.0 2.4 0.4 5.9 18.6 7.5 0.0 0.2 Not available
100.0% 95.1% 95.9% 90.0% 100.0% Insufficient data
100.0% 99.4% 84.8% 90.0% 100.0% Insufficient data
72.0% 77.4% Not applicable Not applicable
32.0% 29.0% Not applicable Not applicable
4.3% 70.6% 93.8% 95.5% Insufficient data
0.0% 64.7% 93.8% 22.7% Insufficient data
98.6% 79.6% 8.0% Insufficient data
47.6% 88.6% 14.4% Insufficient data
89.8% 76.0% 92.4% Insufficient data
89.8% 86.7% 90.5% Insufficient data
10.0% 17.6% 0.0% Not applicable
65.3% 57.3% 92.1% 85.1% 56.9% 90.9% 70.9% Green Yellow Red
89.8% 70.2% 79.9% 51.8% 77.9% 90.1% 67.7% Reached or surpassed target
5.0% 29.4% 0.0% Not applicable
0.0% 31.6% 79.8% 91.9% 46.2% 44.4% 87.3%
0.0% 61.3% 94.2% 66.3% 68.4% 41.7% 83.4%
0.5 1.7 0.8 2.3 1.9
1.6 1.2 7.8 3.0
22.2% 13.0% 39.0%
50.8% 8.7% 29.6%
This indicator is not applicable for countries which have no second-level administrative units 2 Adequate specimen defined as blood specimen collected within 28 days of rash onset or other specimen (throat swab, nasopharyngeal swab, cerebrospinal fluid, urine) collected within 5 days of rash onset; excludes epidemiologically-linked cases. 3 Reports only confirmed cases.
Nearly reached target: 1.00–1.99 for non- measles suspected case rate; 10.1–25% for percent clinically confirmed cases; 60–79% for other indicators Substantially below target
4 2
Table 5. Rubella case classification and incidence by country and area, WHO Western Pacific Region, 2014 –2017 as of 20 June 2017 2014 2015 2016 2017 Confirmed and compatible rubella cases Total Annualized Congenital Pending Discarded Compatible confirmed rubella rubella classification cases Lab Epi-linked cases and incidence per syndrome compatible 1 million pop. 0 0 0 0 69 348 0 0 125 0 0 22 3 567 2 317 6 24 167 2 897 84 5 930 106 0 301 31 4 870 0 0 0 0 0 0 0 0 0 0 0 8 0 8 0 5 0 3 7 44 12 0 208 0 1 18 2 300 0 0 0 0 2 0 0 0 17 0 0 0 0 19 0 5 331 0 0 3 9 44 12 0 225 0 1 18 2 650 0.0 0.7 0.6 0.0 0.0 0.1 3.1 3.4 9.4 0.0 5.2 0.0 0.4 0.5 1.5 0.8 -
Country/area
Total Total Total Population Rubella Rubella Rubella confirmed confirmed confirmed Investigated (in incidence per incidence per incidence per and and and for rubella 1 1 million pop. 1 million pop. 1 million pop. millions) compatible compatible compatible 0 31 11 887 1 0 18 226 0 343 2 0 50 2
Australia Brunei Darussalam Cambodia China China, Hong Kong SAR China, Macao SAR Japan Lao People's Democratic Republic Malaysia Mongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam Pacific island countries and areas Western Pacific Region 1 2
0.0 2.1 8.7 0.1 0.0 2.8 7.5 0.0 3.4 0.0 0.0 0.5 1.2 0.4
0 18 8 245 12 2 2 24 34 28 4 154 2 1 972 0 1 253
0.0 1.1 5.9 1.6 3.5 0.0 3.4 1.1 9.8 0.5 1.5 0.0 0.2 10.4 0.0 0.7
0 4 4 476 3 1 3 40 68 27 2 165 3 0 350 1 667
0.0 0.3 3.2 0.4 1.7 0.0 5.8 2.2 9.0 0.3 1.6 0.1 0.0 3.7 0.3 0.4 Green Yellow Red Gray
24.64 0.43 16.08 1 388.23 7.40 0.61 126.05 7.04 31.16 3.05 4.60 7.93 103.80 50.70 5.78 95.41 3.28 1 876.21
2 322 14 590 0 6 27 245 3 289 105 5 1 280 106 1 349 36 20 363
4 675
United Nations, Department of Economic and Social Affairs, Population Division World Population Prospects. Classification is provisional based on laboratory data only.
<1 confirmed measles case / 1 000 000 population 1–9.9 confirmed measles case / 1 000 000 population >= 10 confirmed cases / 1 000 000 population No data
"-" No data
5
Table 6A. Measles and rubella laboratory testing, WHO Western Pacific Region, 2016 as of 20 February 2017 Measles Measles and rubella Serum Country/area Laboratory Total Total number number of of samples samples received tested 92 16 719 600 46 1 585 254 8 579 10 031 842 40 1 612 633 813 332 870 183 77 243 15 27 582
Serology Blood Measles IgM equiv DBS samples Samples tested for Measles IgM (+) measles IgM No. 22 13 596 538 46 206 254 6 256 9 749 221 40 1 524 400 243 313 865 182 77 233 15 21 793
Total number of cases tested 67 13 719 509 46 802 254 6 593 9 996 757 40 1 610 530 724 318 868 183 77 243 15 24 364
No. 14 1 54 9 3 44 2 1 620 4 969 22 0 36 51 25 1 39 2 0 5 0 6 897
% 63.6 7.7 9.1 1.7 6.5 21.4 0.8 25.9 51.0 10.0 2.4 12.8 10.3 0.3 4.5 1.1 2.1 0.0 31. 6
No. 4 1 0 16 2 34 4 180 981 10 0 31 33 0 1 20 1 0 4 0 1 322
% 18% 8% 0% 3% 4% 17% 2% 3% 10% 5% 0% 2% 8% 0% 0% 2% 1% 0% 2% 0% 6%
No. received 0 0 123 0 0 0 0 0 0 0 0 51 0 0 0 0 0 0 9 15 198
No. (+) 2 5 0 0 7
Rubella Virus detection Serum and blood (includes DBS) Measles Virus Measles isolation/ Reverse Total % of Samples detection Transcription- number of Rubella samples tested for Rubella IgM (+) (swab, urine and Polymerase Chain lab IgM equiv with rubella IgM others) Reaction confirmed results ≤4 No. of No. of cases No. of days No. No. % No. % samples samples No. (+) isolates tested tested 72.7 92.3 80.9 89.0 93.0 100.0 80.7 93.6 99.8 98.2 7.5 98.9 82.9 100.0 96.1 85.2 51.1 20.8 95.1
Australia Brunei Darussalam Cambodia China China, Hong Kong SAR China, M acao SAR Japan Lao People's Democratic Republic M alaysia M ongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam national lab (Northern) Viet Nam national lab (Southern) Viet Nam subnational lab (Central) Viet Nam subnational lab (Highland) Fiji Vanuatu Total "-" No data
VIDRL DLS NIPH CCDC PHLC PHL NIID NCLE NPHL NCCD CHL CPHL RITM KCDC SGH NIHE PI PI IHE FCCDC FCCDC
92 16 719 600 46 1 398 254 6 593 10 031 842 40 1 612 633 813 332 870 183 77 243 15 25 409
0 0 0 5 0 0 0 1 264 1 1 0 62 0 186 10 5 0 0 0 0 1 534
4 122 0 0 0 6 0 0 132
66 1 0 64 1 669 0 0 286 590 0 62 222 0 19 5 1 0 0 0 1 986
60 1 20 0 146 142 68 0 17 0 0 0 454
58 1 44 12 3 156 0 1 662 5 076 79 0 40 55 25 1 39 2 0 5 0 7 258
7 13 719 535 46 10 254 4 513 6 506 157 40 1 576 244 347 313 865 182 77 243 15 16 662
2 0 4 3 4 1 8 108 31 1 1 110 25 2 31 384 10 0 1 0 726
28.6 0.0 0.6 0.6 8.7 3.1 2.4 0.6 2.5 7.0 10.2 0.6 9.9 44.4 5.5 0.0 0.4 0.0 4.4
0 0 0 3 1 0 9 53 15 0 2 62 18 0 15 24 3 1 0 1 207
0% 0% 0% 1% 2% 0% 4% 1% 0% 0% 5% 4% 7% 0% 5% 3% 2% 1% 0% 7% 1%
6
Table 6B. Measles and rubella laboratory testing, WHO Western Pacific Region, 2017 as of 20 June 2017 Measles Measles and rubella Serum Country/area Laboratory Total Total number number of of samples samples received tested 46 2 268 122 20 699 171 4 717 433 183 5 1 040 214 207 109 124 52 6 39 8 457
Serology Blood Measles IgM equiv DBS samples Samples tested for Measles IgM (+) measles IgM No. 5 2 268 104 20 94 171 3 433 427 61 5 982 142 30 107 124 52 6 38 6 071
Total number of cases tested 39 2 268 103 20 375 171 3 564 433 167 5 1 040 173 201 109 124 52 6 38 6 890
No. 3 0 9 3 0 32 2 596 3 4 0 14 16 5 3 3 0 0 1 694
% 60.0 0.0 3.4 2.9 0.0 34.0 1.2 17.4 0.7 6.6 1.4 11.3 16.7 2.8 2.4 0.0 2.6 11. 4
No. 2 1 0 3 0 11 5 103 13 3 0 14 8 0 2 1 1 0 0 167
% 40% 50% 0%
No. received 0 0 54 -
No. (+) 0 1 0 1
Rubella Virus detection Serum and blood (includes DBS) Measles Virus Measles isolation/ Reverse Total % of Samples detection Transcription- number of Rubella samples tested for Rubella IgM (+) (swab, urine and Polymerase Chain lab IgM equiv with rubella IgM others) Reaction confirmed results ≤4 No. of No. of cases No. of days No. No. % No. % samples samples No. (+) isolates tested tested 100.0 100.0 63.4 91.2 91.9 100.0 92.4 95.0 100.0 96.7 80.0 96.2 89.3 100.0 97.2 87.9 26.9 0.0 93.0
Australia Brunei Darussalam Cambodia China China, Hong Kong SAR China, M acao SAR Japan Lao People's Democratic Republic M alaysia M ongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam national lab (Northern) Viet Nam national lab (Southern) Viet Nam subnational lab (Central) Viet Nam subnational lab (Highland) Fiji Total "-" No data
VIDRL DLS NIPH CCDC PHLC PHL NIID NCLE NPHL NCCD CHL CPHL RITM KCDC NPHL NIHE PI PI IHE FCCDC
46 2 268 122 20 674 171 4 717 433 183 5 1 040 214 207 109 124 52 6 39 8 432
0 0 0 5 0 0 0 753 0 0 0 61 0 25 2 0 0 0 0 846
2 41 0 8 0 51
42 0 0 22 0 332 0 6 6 104 0 110 63 163 2 0 0 0 0 850
42 7 153 0 10 0 2 25 0 239
38 0 9 3 0 160 0 617 0 10 0 14 17 29 3 3 0 0 1 904
0 2 321 97 20 5 169 2 733 404 60 5 1 039 81 25 107 124 52 6 38 5 288
0 5 0 0 0 8 59 4 0 0 184 12 2 8 9 1 0 3 295
0.0 1.6 0.0 0.0 4.7 2.2 1.0 0.0 0.0 17.7 14.8 8.0 7.5 7.3 0.0 7.9 5.6
0 0 1 1 0 7 58 24 0 0 55 12 0 3 6 0 0 0 167
0% 0% 1% 5% 0% 4% 2% 6% 0% 0% 5% 15% 0% 3% 5% 0% 0% 0% 3%
3% 0% 12% 3% 3% 3% 5% 0% 1% 6% 0% 2% 1% 2% 0% 0% 3%
0 0 0 0 0 0 0 0 26 0 0 0 0 0 0 1 81
7
Figure 3. Measles genotype distribution of cases with rash onset in 2016 and 2017, WHO Western Pacific Region
2016
2017
B3 D4 D8 D9 The boundaries and names shown and the designations used on the maps do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO Regional Office for the Western Pacific 2009. All rights reserved.
D11 G3 H1
Table 7. Measles genotype distribution of cases with rash onset in June 2016 to May 2017, WHO Western Pacific Region 2016 Country/area Australia Brunei Darussalam Cambodia China China, Hong Kong SAR China, Macao SAR Japan Lao People's Democratic Republic Malaysia Mongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam Pacific island countries and areas
2017
Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D4 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 5 1 4 8 1 7 8 15 2 3 11 11 3 2 4 4 11 4 2 5 7 1 3 241 131 42 18 2 3 11 47 37 1 59 1 33 2 1 2 2 1 1 4 14 44 22 10 10 1 1 8 1 10 4 2 1 1 14 3 3 1 4 1 1 16 1 1 2 1 2 52 2 50 1
1 2 2 3 1 6 5 2 3
10 16 2 10 2
1 5
2
2
4
5
4
1
Sources: Includes all cases reported to the Western Pacific Regional Office by 20 June 2017 and the Measles Nucleotide Surveillance online database (MeaNS).
8
Figure 4. Rubella genotype distribution of cases with rash onset in 2016 and 2017, WHO Western Pacific Region
2016
2017
2B 1E
The boundaries and names shown and the designations used on the maps do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO Regional Office for the Western Pacific 2009. All rights reserved.
Table 8. Rubella genotype distribution of cases with rash onset in June 2016 to May 2017, WHO Western Pacific Region Country/area Australia Brunei Darussalam Cambodia China China, Hong Kong SAR China, Macao SAR Japan Lao People's Democratic Republic Malaysia Mongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam Pacific island countries and areas Sources: Includes all cases reported to the Western Pacific Regional Office by 20 June 2017 and the Rubella Nucleotide Surveillance online database (RubeNS).
2016 2017 Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 1
6 1 4
2
1
1
2
18
6
1
11
1
1
1
1
1 1 6 1 5 4 2
9
Table 9A. Completeness and timeliness of epidemiologic reporting, WHO Western Pacific Region, 2016 —2017 Country Australia Brunei Darussalam Cambodia China China, Hong Kong SAR China, Macao SAR Japan Lao People's Democratic Republic Malaysia Mongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam Pacific island countries and areas Completeness Timeliness 1 2 3
2016 Completeness 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 92% 100% 100% 100% 100% 100% 100% 2
1
2017 3
1
Timeliness 75% 100% 100% 83% 100% 100% 100% 100% 100% 83% 100% 50% 75% 100% 100% 92% 100%
Jan 10 Feb 07 Feb 10 Feb 15 Feb 10 Feb 07 Feb 06 Feb 10 Feb 07 Feb 09 Feb 09 Feb 08 Feb 10 Feb 08 Feb 09 Feb 14 Feb 100%
Feb 09 Mar 06 Mar 10 Mar 11 Mar 09 Mar 07 Mar 09 Mar 10 Mar 09 Mar 07 Mar 07 Mar 08 Mar 09 Mar 09 Mar 10 Mar 14 Mar 100% 94%
Mar 10 Apr 08 Apr 10 Apr 18 Apr 06 Apr 05 Apr 10 Apr 10 Apr 10 Apr 06 Apr 07 Apr 13 Apr 31 Mar 10 Apr 10 Apr 07 Apr 13 Apr 100% 88%
Apr 10 May 06 May 10 May 10 May 02 May 05 May 10 May 10 May 09 May 09 May 05 May 10 May 05 May 10 May 08 May 09 May 15 May 100% 100%
May 09 Jun 06 Jun 10 Jun 04 Jun 06 Jun 02 Jun 09 Jun 10 Jun 09 Jun 07 Jun 08 Jun 09 Jun 10 Jun 08 Jun 09 Jun 08 Jun 16 Jun 100% 94%
Completeness 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 80% 100% 100% 100% 100% 100% 100%
2
Timeliness 100% 100% 100% 80% 100% 100% 100% 100% 100% 100% 100% 80% 60% 100% 100% 100% 80%
3
92%
94%
94%
National measles surveillance monthly reports from May 2017.
Legend: black = timely report; red = untimely report
Completeness is defined as the number of reports received by the end of the reporting month divided by the number of expected reports for the year. Countries and areas should submit reports by the 10th (or the next working day) of the following month; Pacific island countries and areas and China may report to the Regional Office
by the 15th (or the next working day) of the following month.
Table 9B. Completeness and timeliness of laboratory reporting, WHO Western Pacific Region, 2016 —2017 2016 Country/area 2017 1
Genotype results by source of data Completeness 2 Timeliness 3
Jan
Feb
Mar
Apr
May
Completeness 2
Timeliness
3
Measles MeaNS Submission to WPRO 29 0 0 180 3 0 120 0 0 0 7 0 0 1 23 0 0 0 0 0 363
Rubella Rubens 1 0 0 18 0 0 3 0 0 0 1 0 18 0 0 0 0 0 0 0 41 20 Submission to WPRO 0 0 0 18 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0
Australia Brunei Darussalam Cambodia China China, Hong Kong SAR China, Macao SAR Japan Lao People's Democratic Republic Malaysia Mongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam national lab (Northern) Viet Nam national lab (Southern) Viet Nam subnational lab (Central) Viet Nam subnational lab (Highland) Fiji Completeness Timeliness 1 2 3
100% 100% 100% 100% 100% 100% 100% 100% 100% 92% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100%
100% 100% 100% 100% 100% 100% 100% 100% 83% 67% 100% 33% 92% 100% 100% 92% 100% 92% 92% 92%
03 Feb 04 Feb 10 Feb 03 Feb 09 Feb 07 Feb 06 Feb 10 Feb 08 Feb 10 Feb 09 Feb 13 Feb 21 Feb 10 Feb 08 Feb 07 Feb 10 Feb 07 Feb 07 Feb 14 Feb 100%
06 Mar 02 Mar 10 Mar 06 Mar 07 Mar 08 Mar 09 Mar 10 Mar 09 Mar 06 Mar 07 Mar 10 Mar 08 Mar 10 Mar 09 Mar 07 Mar 08 Mar 07 Mar 07 Mar 14 Mar 100% 100%
04 Apr 03 Apr 10 Apr 10 Apr 06 Apr 07 Apr 10 Apr 10 Apr 10 Apr 10 Apr 07 Apr 10 Apr 07 Apr 10 Apr 10 Apr 03 Apr 07 Apr 03 Apr 03 Apr 13 Apr 100% 95%
02 May 29 Apr 10 May 03 May 05 May 05 May 10 May 10 May 09 May 10 May 05 May 10 May 10 May 10 May 08 May 10 May 05 May 10 May 10 May 15 May 100% 100%
06 Jun 01 Jun 10 Jun 06 Jun 07 Jun 02 Jun 09 Jun 10 Jun 08 Jun 10 Jun 08 Jun 15 Jun 08 Jun 09 Jun 09 Jun 02 Jun 09 Jun 02 Jun 02 Jun 16 Jun 100% 90%
100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100%
100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 60% 80% 100% 100% 100% 100% 100% 100% 80%
45 0 0 179 3 0 3 0 6 0 10 0 0 1 0 0 0 0 0 0 247
92%
100%
95% Legend: black = timely report; red = untimely report
National measles laboratory monthly reports from May 2017. Completeness is defined as the number of reports received by the end of the reporting month divided by the number of expected reports for the year. National measles and rubella laboratories should submit monthly reports by the 10th (or the next working day) of the following month.
Expanded Programme on Immunization Regional Office for the Western Pacific World Health Organization P.O. Box 2932, 1000 Manila, Philippines Tel. No. (63 2) 5288001 Fax No. (63 2) 5211036, 5260279 Please send your comments and monthly data before the 10th of the month to: WPROEPIdata@who.int More detailed information available in the Regional and country profile of measles elimination
10